Erin L Hsu

  • 686 Citations
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

The overarching focus of their research is the process of osteogenic differentiation, or the differentiation of stem cells into bone-forming cells. Aiming to develop musculoskeletal tissue regenerative technologies that are both safer and more effective than currently available products, their bone regeneration work includes the development of novel approaches to induce bone growth, such as the use of peptide amphiphile nanofiber scaffolds to deliver ultra low-dose growth factor, enhance the utility of autograft bone, and deliver stem cells to promote bone regeneration. They also work to develop 3D-printed osteoregenerative scaffolds, with a goal to create products that elicit high rates of spine fusion without the need for exogenous growth factors, such as bone morphogenetic protein-2. The Hsu group’s bone toxicology team continues to explore the molecular mechanisms by which pervasive environmental contaminants—such as those present in cigarette smoke—inhibit osteoblastic differentiation and bone healing. Their major focus is dioxin-like compounds and other aryl hydrocarbons, which are potent carcinogens that also inhibit bone healing. Their work ultimately aims to identify a therapeutic approach to mitigate those inhibitory effects, with a particular interest in natural phytochemical-based therapeutics (or “nutraceuticals”), such as resveratrol. They have found that resveratrol, which is found in red wine, provides protection against the effects of cigarette smoke on bone forming cells, and they are now exploring the utility nanofiber scaffolds to co-deliver low-dose growth factor and resveratrol or other phytochemicals in a setting of cigarette smoke exposure.

After receiving her bachelor’s degree from Vanderbilt University, Erin Hsu completed her PhD in Molecular Toxicology at UCLA in 2007, where she studied the role of the Aryl hydrocarbon receptor in both carcinogenesis and phytochemical-based chemoprevention. After completing post-doctoral training in the laboratory of Dr. Christopher Bradfield in the University of Wisconsin McArdle Laboratory for Cancer Research, Erin joined the Feinberg School of Medicine's Department of Orthopaedic Surgery, where she pursues research focused on bone regeneration and healing. As resident faculty in the Simpson Querrey Institute for BioNanotechnology (SQI), the Hsu group’s laboratory space is located within this state-of-the-art facility, in close proximity to many of their materials scientist collaborators. Erin also serves as Assistant Director of the Simpson Querrey Institute.

Education/Academic qualification

PhD, University of California-Los Angeles

… → 2007

Research interests

  • Biologic Therapies
  • Environmental Health
  • Molecular Biology
  • Nanotechnology
  • Orthopedics
  • Signal Transduction
  • Toxicology
  • Transdisciplinary Research

Fingerprint Dive into the research topics where Erin L Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Arthrodesis Medicine & Life Sciences
Aryl Hydrocarbon Receptors Medicine & Life Sciences
Dioxins Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences
Spinal Fusion Medicine & Life Sciences
Bone Morphogenetic Protein 2 Medicine & Life Sciences
Bone Regeneration Medicine & Life Sciences
Spine Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2010 2023

Intercellular Signaling Peptides and Proteins
Bone and Bones
Intercellular Signaling Peptides and Proteins
Bone and Bones
Bone Substitutes

Research Output 2005 2019

  • 686 Citations
  • 27 Article
  • 1 Conference contribution
  • 1 Review article
1 Citation (Scopus)

The Effect of Proton Pump Inhibitors on Bone Formation in a Rat Spinal Arthrodesis Model

Sonn, K. A., Wallace, S. J., Yuan, F. N. F., Schneider, A. D., Hsu, E. L., Havey, R. M., Patwardhan, A. G. & Callaci, J. J., Jul 15 2019, In : Spine. 44, 14, p. E815-E822

Research output: Contribution to journalArticle

Proton Pump Inhibitors
X-Ray Microtomography
2 Citations (Scopus)

Aryl hydrocarbon receptor antagonists mitigate the effects of dioxin on critical cellular functions in differentiating human osteoblast-like cells

Yun, C., Katchko, K. M., Schallmo, M. S., Jeong, S., Yun, J., Chen, C. H., Weiner, J. A., Park, C., George, A., Stupp, S., Hsu, W. K. & Hsu, E. L., Jan 11 2018, In : International journal of molecular sciences. 19, 1, 225.

Research output: Contribution to journalArticle

Aryl Hydrocarbon Receptors
3 Citations (Scopus)

Environmental factors impacting bone-relevant chemokines

Smith, J. T., Schneider, A. D., Katchko, K. M., Yun, C. & Hsu, E. L., Feb 14 2017, In : Frontiers in Endocrinology. 8, FEB, 22.

Research output: Contribution to journalArticle

Bone and Bones
Endocrine Disruptors
CXC Chemokines
Volatile Organic Compounds
15 Citations (Scopus)

Intra-articular vancomycin powder eliminates methicillin-resistant S. aureus in a rat model of a contaminated intra-articular implant

Edelstein, A. I., Weiner, J. A., Cook, R. W., Chun, D. S., Monroe, E., Mitchell, S. M., Kannan, A., Hsu, W. K., David Stulberg, S. & Hsu, E. L., Jan 1 2017, In : Journal of Bone and Joint Surgery - American Volume. 99, 3, p. 232-238 7 p.

Research output: Contribution to journalArticle

Methicillin Resistance
Methicillin-Resistant Staphylococcus aureus
5 Citations (Scopus)

Mechanistic insight into the effects of Aryl Hydrocarbon Receptor activation on osteogenic differentiation

Yun, C., Weiner, J. A., Chun, D. S., Yun, J., Cook, R. W., Schallmo, M. S., Kannan, A. S., Mitchell, S. M., Freshman, R. D., Park, C., Hsu, W. K. & Hsu, E. L., Jun 1 2017, In : Bone Reports. 6, p. 51-59 9 p.

Research output: Contribution to journalArticle

Aryl Hydrocarbon Receptors
Bone Regeneration
Mesenchymal Stromal Cells
Bone and Bones